Email Updates

You are here

Webinar & Meeting Reports

  • May 31, 2022

    On Tuesday, May 31, AVAC and partners held Prospects, the third webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the what we have learned, why it matters and what it means. They looked at recent results in HIV vaccine research and implications for the future, unpacked results from Uhambo and Imbokodo trials and talked about the implications for the current pipeline of products.

  • May 24, 2022

    On Tuesday, May 24, 2022, AVAC and partners held Processes, the second webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the changed landscape of clinical research and the potential for experimental medicine vaccine trials in the current research environment.

  • May 18, 2022

    On Wednesday, May 18, 2022, AVAC and partners held Platforms & Pipelines, the first webinar in our HVAD 2022 webinar series. The moderators and panelists will discussed the miracle of mRNA—its history and potential challenges for HIV vaccines and what’s possible beyond SARS-CoV-2.

  • May 18, 2022

    This year marks the 25th anniversary of HIV Vaccine Awareness Day. Nothing about HIV vaccine research has ever been easy, and this past year has shown us how difficult this research is, and how essential it continues to be.

  • April 27, 2022

    On Wednesday, April 27, the CROI Community Liaison Subcommittee, AVAC, and European AIDS Treatment Group (EATG) held a webinar to debrief this year's Conference on Retroviruses and Opportunistic Infections. Following a brief overview of some of the most notable science presented at CROI 2022, a panel of community discussants from around the world unpacked findings from the conference, shared perspectives, and offered advocacy suggestions. Topics will spanned science presented on HIV prevention and treatment, HIV and aging, HIV cure, and COVID-19 — among others.

  • April 20, 2022 to April 21, 2022

    The 6th annual Biomedical HIV Prevention Summit will take place in person on April 20-21 in Chicago, Illinois at the Sheraton Grand Chicago Riverwalk. The Summit will highlight the role that biomedical prevention tools such as PrEP, PEP, Treatment as Prevention (TasP) and U=U have in ending the epidemic while working in the current COVID environment.

  • April 12, 2022

    On April 12, AVAC and FP2030 convened a consultation with family planning (FP) and sexual and reproductive health (SRH) stakeholders to understand their unique perspectives on the Dual Prevention Pill (DPP), a daily pill that prevents HIV and pregnancy. The consultation focused on key issues that must inform plans for DPP introduction plans and the development and delivery of future multi-purpose prevention technologies (MPTs).

  • April 6, 2022

    On April 6, 2022, the COVID Advocates Advisory Board (CAAB) and AVAC's Coalition to Accelerate and Support Prevention Research (CASPR) hosted a special webinar on the Ubuntu trial. Led by the COVID-19 Prevention Network (CoVPN), Ubuntu is a landmark COVID-19 vaccine trial in sub-Saharan Africa investigating the efficacy of mRNA vaccines in people living with HIV against the omicron variant.

  • April 6, 2022

    While there are a number of resources that address stakeholder engagement in COVID-19 research, some may not adequately reflect the needs of advocates. Join a conversation reviewing resources for advocates' needs and shaping future resources!

  • April 5, 2022

    Researchers broke down the recent case of HIV cure, the first among women. Speakers also provided updates from an ongoing trial studying pediatric remission. Participants learned what these advances mean for science and for people living with HIV.